UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 454

Sortiert nach

All‐oral direct‐acting antiviral therapy in HCV‐advanced liver disease is effective in real‐world practice: observations through HCV‐TARGET database

Alimentary pharmacology & therapeutics, 2017-01, Vol.45 (1), p.115-126

2017

Link zum Volltext

Verfügbarkeit prüfen

The Australia and New Zealand Fontan Registry: description and initial results from the first population-based Fontan registry

Internal medicine journal, 2014-02, Vol.44 (2), p.148-155

2014

Link zum Volltext

Verfügbarkeit prüfen

The extracardiac conduit Fontan procedure in Australia and New Zealand: hypoplastic left heart syndrome predicts worse early and late outcomes

European journal of cardio-thoracic surgery, 2014-09, Vol.46 (3), p.465-473

2014

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of repair of complete atrioventricular septal defect in the current era

European journal of cardio-thoracic surgery, 2014-04, Vol.45 (4), p.610-617

2014

Link zum Volltext

Verfügbarkeit prüfen

Decreased cortical muscarinic M1 receptors in schizophrenia are associated with changes in gene promoter methylation, mRNA and gene targeting microRNA

Translational psychiatry, 2013-02, Vol.3 (2), p.e230-e230

2013

Link zum Volltext

Verfügbarkeit prüfen

Association of in vitro fertilization with global and IGF2/H19 methylation variation in newborn twins

Journal of developmental origins of health and disease, 2015-04, Vol.6 (2), p.115-124

2015

Link zum Volltext

Verfügbarkeit prüfen

Liver Transplantation for Acute Hepatic Decompensation Achieves Excellent Outcomes without Increased Recidivism Rates: A Single Center Experience

Journal of hepatology, 2016, Vol.64 (2), p.S539-S539

2016

Link zum Volltext

Verfügbarkeit prüfen

What Is Meant by "Missing at Random"?

Statistical science, 2013-05, Vol.28 (2), p.257-268

2013

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Refractory Gastrointestinal Bleeding in Patients With Portal Hypertension: A Case Series and Treatment Algorithm

Transplantation proceedings, 2017-10, Vol.49 (8), p.1864-1869

2017

Link zum Volltext

Verfügbarkeit prüfen

2016 LONG-TERM OUTCOMES FOLLOWING COMBINATION TREATMENT WITH BOCEPREVIR PLUS PEG-INTRON/RIBAVIRIN (P/R) IN PATIENTS WITH CHRONIC HEPATITIS C, GENOTYPE 1 (CHC-G1)

Journal of hepatology, 2010, Vol.52, p.S470-S471

2010

Link zum Volltext

Verfügbarkeit prüfen

P1222 A PHASE II STUDY OF SAMATASVIR (IDX719) IN COMBINATION WITH SIMEPREVIR AND RIBAVIRIN IN TREATMENT-NAÏVE HCV-INFECTED SUBJECTS WITH GENOTYPES 1B AND 4 (HELIX-1 STUDY)

Journal of hepatology, 2014-04, Vol.60 (1), p.S495-S496

2014

Link zum Volltext

Verfügbarkeit prüfen

Rounding non-binary categorical variables following multivariate normal imputation: evaluation of simple methods and implications for practice

Journal of statistical computation and simulation, 2014-04, Vol.84 (4), p.798-811

2014

Link zum Volltext

Verfügbarkeit prüfen

11 SUSTAINED VIROLOGIC RESPONSE (SVR) IN PRIOR PEGINTERFERON/RIBAVIRIN (PR) TREATMENT FAILURES AFTER RETREATMENT WITH BOCEPREVIR (BOC)-+-PR: THE PROVIDE STUDY INTERIM RESULTS

Journal of hepatology, 2012-04, Vol.56, p.S6-S6

2012

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection

Gastroenterology (New York, N.Y. 1943), 2016-02, Vol.150 (2), p.419-429

2016

Link zum Volltext

Verfügbarkeit prüfen

Boceprevir for Untreated Chronic HCV Genotype 1 Infection

The New England journal of medicine, 2011-03, Vol.364 (13), p.1195-1206

2011

Link zum Volltext

Verfügbarkeit prüfen

Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection

The New England journal of medicine, 2011-03, Vol.364 (13), p.1207-1217

2011

Link zum Volltext

Verfügbarkeit prüfen

The role of choledochoscopy in the diagnosis and management of biliary tract diseases

Gastrointestinal endoscopy, 1999-07, Vol.50 (1), p.67-73

1999

Link zum Volltext

Verfügbarkeit prüfen

991 FINAL RESULTS OF THE IDEAL (INDIVIDUALIZED DOSING EFFICACY VERSUS FLAT DOSING TO ASSESS OPTIMAL PEGYLATED INTERFERON THERAPY) PHASE IIIB STUDY

Journal of hepatology, 2008, Vol.48, p.S370-S371

2008

Link zum Volltext

Verfügbarkeit prüfen

Lung Tumorigenic Interactions in Strain A/J Mice of Five Environmental Polycyclic Aromatic Hydrocarbons

Environmental health perspectives, 1998-12, Vol.106 (suppl 6), p.1337-1346

1998

Link zum Volltext

Verfügbarkeit prüfen

4 HCV SPRINT-1 FINAL RESULTS: SVR 24 FROM A PHASE 2 STUDY OF BOCEPREVIR PLUS PEGINTRON™ (PEGINTERFERON ALFA-2B)/RIBAVIRIN IN TREATMENT- NAIVE SUBJECTS WITH GENOTYPE-1 CHRONIC HEPATITIS C

Journal of hepatology, 2009, Vol.50, p.S4-S4

2009

Link zum Volltext

Verfügbarkeit prüfen

Inhibitory effects on phenethyl isothiocyanate on N-nitrosobenzylmethylamine carcinogenesis in the rat esophagus

Cancer research (Chicago, Ill.), 1991-04, Vol.51 (8), p.2063-2068

1991

Link zum Volltext

Verfügbarkeit prüfen

995 INTERIM RESULTS FROM HCV SPRINT-1: RVR/EVR FROM PHASE 2 STUDY OF BOCEPREVIR PLUS PEGINTRONTM (PEGINTERFERON ALFA-2B)/RIBAVIRIN IN TREATMENT-NAIVE SUBJECTS WITH GENOTYPE-1 CHC

Journal of hepatology, 2008, Vol.48, p.S372-S372

2008

Link zum Volltext

Verfügbarkeit prüfen

Dose-related inhibition by dietary phenethyl isothiocyanate of esophageal tumorigenesis and DNA methylation induced by N-nitrosomethylbenzylamine in rats

Cancer letters, 1993-08, Vol.72 (1), p.103-110

1993

Link zum Volltext

Verfügbarkeit prüfen

Anemia during treatment with peginterferon Alfa‐2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT‐2) trial

Hepatology (Baltimore, Md.), 2013-03, Vol.57 (3), p.974-984

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 454

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(409)
Mit Volltextzugriff
(415)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

All‐oral direct‐acting antiviral therapy in HCV‐advanced liver disease is effective in real‐world practice: observations through HCV‐TARGET database

The Australia and New Zealand Fontan Registry: description and initial results from the first population-based Fontan registry

The extracardiac conduit Fontan procedure in Australia and New Zealand: hypoplastic left heart syndrome predicts worse early and late outcomes

Outcomes of repair of complete atrioventricular septal defect in the current era

Decreased cortical muscarinic M1 receptors in schizophrenia are associated with changes in gene promoter methylation, mRNA and gene targeting microRNA

Association of in vitro fertilization with global and IGF2/H19 methylation variation in newborn twins

Liver Transplantation for Acute Hepatic Decompensation Achieves Excellent Outcomes without Increased Recidivism Rates: A Single Center Experience

What Is Meant by "Missing at Random"?

Treatment of Refractory Gastrointestinal Bleeding in Patients With Portal Hypertension: A Case Series and Treatment Algorithm

2016 LONG-TERM OUTCOMES FOLLOWING COMBINATION TREATMENT WITH BOCEPREVIR PLUS PEG-INTRON/RIBAVIRIN (P/R) IN PATIENTS WITH CHRONIC HEPATITIS C, GENOTYPE 1 (CHC-G1)

P1222 A PHASE II STUDY OF SAMATASVIR (IDX719) IN COMBINATION WITH SIMEPREVIR AND RIBAVIRIN IN TREATMENT-NAÏVE HCV-INFECTED SUBJECTS WITH GENOTYPES 1B AND 4 (HELIX-1 STUDY)

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

Rounding non-binary categorical variables following multivariate normal imputation: evaluation of simple methods and implications for practice

11 SUSTAINED VIROLOGIC RESPONSE (SVR) IN PRIOR PEGINTERFERON/RIBAVIRIN (PR) TREATMENT FAILURES AFTER RETREATMENT WITH BOCEPREVIR (BOC)-+-PR: THE PROVIDE STUDY INTERIM RESULTS

Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection

Boceprevir for Untreated Chronic HCV Genotype 1 Infection

Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection

The role of choledochoscopy in the diagnosis and management of biliary tract diseases

991 FINAL RESULTS OF THE IDEAL (INDIVIDUALIZED DOSING EFFICACY VERSUS FLAT DOSING TO ASSESS OPTIMAL PEGYLATED INTERFERON THERAPY) PHASE IIIB STUDY

Lung Tumorigenic Interactions in Strain A/J Mice of Five Environmental Polycyclic Aromatic Hydrocarbons

4 HCV SPRINT-1 FINAL RESULTS: SVR 24 FROM A PHASE 2 STUDY OF BOCEPREVIR PLUS PEGINTRON™ (PEGINTERFERON ALFA-2B)/RIBAVIRIN IN TREATMENT- NAIVE SUBJECTS WITH GENOTYPE-1 CHRONIC HEPATITIS C

Inhibitory effects on phenethyl isothiocyanate on N-nitrosobenzylmethylamine carcinogenesis in the rat esophagus

995 INTERIM RESULTS FROM HCV SPRINT-1: RVR/EVR FROM PHASE 2 STUDY OF BOCEPREVIR PLUS PEGINTRONTM (PEGINTERFERON ALFA-2B)/RIBAVIRIN IN TREATMENT-NAIVE SUBJECTS WITH GENOTYPE-1 CHC

Dose-related inhibition by dietary phenethyl isothiocyanate of esophageal tumorigenesis and DNA methylation induced by N-nitrosomethylbenzylamine in rats

Anemia during treatment with peginterferon Alfa‐2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT‐2) trial

Suchergebnisse filtern